Home › Opioid Overdose › NCT07362082

A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Can speak, read and write in English
* Provision of signed and dated informed consent form
* Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
* Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer)
* Can provide a working email address OR be willing to create one

Exclusion Criteria:

* Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
* Pregnancy
* Known current suicide risk based on participant self-report
* On parole or incarcerated at time of enrollment based on participant self-report

About the study

This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.

What is being tested

• RecoveryPad platform (device)

Sponsor: Yale University · Participants: 470 · Started: Sep 11, 2026

Contact the study team

• Rebekah Heckmann, MD · Phone: (203) 737-8335

Official record on ClinicalTrials.gov — NCT07362082

Locations in the U.S.

Conditions

• Opioid Overdose

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.